Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

VaxGen to acquire diaDexus in stock-for-stock merger
Bizjournals.com
Thursday, April 15, 2010 - 8:47am
tags:
diaDexus, VaxGen, M&A
Dynavax, Santarus: Early Volume Plays
TheStreet.com
Thursday, April 15, 2010 - 8:46am
tags:
Dynavax, Santarus
Can Tianyin Pharmaceutical Heal Your Portfolio?
Seeking Alpha
Thursday, April 15, 2010 - 8:44am
tags:
Tianyin Pharmaceutical, China
Sanofi-Aventis diabetes drug meets study endpoints
Marketwatch
Thursday, April 15, 2010 - 8:43am
tags:
diabetes, Sanofi, lixisenatide
Oops, This Drug Works Too Well
Motley Fool
Thursday, April 15, 2010 - 8:42am
tags:
Roche, InterMune, danoprevir, hepatitis C
Novartis Reorganizes US Operations, CEO Leaves
Pharmalot
Wednesday, April 14, 2010 - 2:02pm
tags:
Novartis, reorganization
Genzyme sees MS drug topping efficacy league
Reuters
Wednesday, April 14, 2010 - 1:59pm
tags:
Genzyme, Campath, multiple sclerosis, MS
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wednesday, April 14, 2010 - 1:56pm
tags:
MS, Acorda Therapeutics, AMPYRA, multiple sclerosis
How much is too much to pay for Provenge?
Fierce Biotech
Wednesday, April 14, 2010 - 11:34am
tags:
Provenge, Dendreon, prostate cancer
Forest Labs: Earnings Preview
Yahoo/Zacks.com
Wednesday, April 14, 2010 - 11:29am
tags:
Forest Labs, earnings
Wall Street sees Astellas nabbing OSI for up to $4.3B
Fierce Pharma
Wednesday, April 14, 2010 - 10:48am
tags:
OSI Pharmaceuticals, Astellas, M&A
Biotech Earnings: Large-Cap Preview
TheStreet.com
Wednesday, April 14, 2010 - 10:46am
tags:
earnings, Amylin, Biogen Idec, Gilead Sciences, Vanda, Genzyme, Amgen, Alexion, Celgene, Allos
Orexigen revises obesity drug data; shares fall
Reuters
Wednesday, April 14, 2010 - 10:44am
tags:
obesity, Orexigen, Contrave
Pozen, Teva settle patent dispute over Treximet
Yahoo/AP
Wednesday, April 14, 2010 - 10:42am
tags:
Pozen, Teva Pharmaceuticals, patents, Treximet
Time To Buy Baxter
Investopedia
Wednesday, April 14, 2010 - 9:15am
tags:
Baxter International
Teva licenses Mersana cancer treatment for $334M
Yahoo/AP
Wednesday, April 14, 2010 - 9:13am
tags:
Teva Pharmaceuticals, Mersana, cancer, liscensing
Access Pharma Readies Oral Oncology Drug for U.S. Sales
Seeking Alpha
Wednesday, April 14, 2010 - 9:09am
tags:
Access Pharmaceuticals, cancer, MuGard
Popular Anticonvulsants Raise Suicide Risks: Study
Pharmalot
Wednesday, April 14, 2010 - 9:08am
tags:
suicide, anticonvulsants, Pfizer, Neurontin, GSK, Lamictal, Novartis, Trileptal, Gabitril, Cephalon, Sanofi, Epilim, Abbott Laboratories, Depakote
CRO industry poised for recovery--followed by a shakeout
Fierce Biotech
Wednesday, April 14, 2010 - 9:05am
tags:
CROs
Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker
Seeking Alpha
Wednesday, April 14, 2010 - 9:04am
tags:
Infinity, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.